Tuesday, January 15, 2019 10:50:23 AM
3 major participants in the last private placement round for $AHG all have direct connections to NAC. Alternative health has also participated in previous NAC PP rounds.
Here is what I have learned.
1) PI Financial Corp. ITF Paskwayak Business Development Corporation Ltd. Opaskwyak, Manitoba Bought 3.75 Million shares in the last Private Placement.
After doing some digging i noticed that Paskwayak Business Development Corporation are First Nations from the Opaskwayak Cree Nation.
- They are heavily invested in National Access Cannabis Corp.
https://ceo.ca/@nasdaq/paskwayak-business-development-corporation-acquires
- They are also invested in Trichome Financial Corp. (Specialty Finance for the Cannabis Industry)
https://www.newswire.ca/news-releases/trichome-financial-corp-announces-closing-of-private-placement-and-provides-corporate-update-692684761.html
2) PI Financial Corp.For: Mark Goliger Burlington, ON bought 125,000 shares. He is CEO of National Access Cannabis.
3) Rocco Meliambro has 750,000 shares. He is on the board of National Access Cannabis Corp
See full list of AHG Private placement participants here: https://webfiles.thecse.com/CSE_Form_9_-_NoticeofIssuanceofSecurities_-_21Dec18_-_final.pdf
Recent AHG News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/08/2024 09:05:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/07/2024 04:57:14 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 02/26/2024 07:48:39 PM
- AHG Announces Plan to Acquire Online Clinic • GlobeNewswire Inc. • 01/31/2024 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/29/2024 09:05:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/22/2024 09:05:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/03/2024 11:18:41 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/17/2023 09:05:06 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/18/2023 08:05:03 PM
- Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement • GlobeNewswire Inc. • 10/16/2023 02:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/02/2023 09:00:36 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 08:30:38 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM